Xuezhe Wang

Impact of seizure frequency reduction on health-related quality of life among clinical trial subjects with refractory partial-onset seizures: A pooled analysis of phase III clinical trials of eslicarbazepine acetate

J. Cramer, D. Blum, T. Bond, 2017, Epilepsy & Behavior.

Severity and burden of partial-onset seizures in a phase III trial of eslicarbazepine acetate

J. Cramer, P. Ryvlin, F. Gilliam, 2015, Epilepsy & Behavior.